Cancer Control and Population Sciences Home

Epidemiology and Genomics Research Home

Consortia (EGRP Facilitated and Funded)

International Lymphoma Epidemiology Consortium

2013 InterLymph Meeting
June 24-26, 2013
Dijon, France

Members of the International Lymphoma Epidemiology Consortium (InterLymph) and other interested individuals are invited to attend the 2013 Annual Meeting at the Faculty of Medicine, University of Dijon in France. The meeting will be held June 24-26, 2013.

• Agenda
• Registration
• Travel, Travel Support, and Directions
• Abstract Submission Guidelines
• Scientific Committee Members
• Sponsors

Agenda

[Return to Top]

Registration

To register for the 2013 InterLymph Annual Meeting, complete the online registration form. Note: Interested individuals must first create a profile on the Mayo Medical Laboratories website.

The registration fee for the conference is $100 per day or $300 if attending all three days of the conference. Contact Aaron Norman for any questions regarding registration.

[Return to Top]

Travel, Travel Support, and Directions

Attendees will be responsible for their own travel arrangements and hotel reservations. More details about the hotel options are available on the meeting registration webpage.

• Travel Support
  View Travel Support Details

  The Lymphoma Coalition is generously providing limited funds for travel support to InterLymph members to attend the 2013 Dijon InterLymph meeting. Funds may be requested for airfare and/or hotel costs. InterLymph members can download the form to request travel support from the InterLymph SharePoint site. Others may request a copy of the form by contacting Aaron Norman. In order for a request for travel support to be considered, complete the form and e-mail it to Aaron Norman by April 31, 2013.

  Requests should summarize the contribution the attendee will make to the 2013 InterLymph meeting, their role in ongoing InterLymph pooling projects, and anticipated airfare and/or hotel costs. In order to maximize the number of investigators that can be supported, InterLymph does not anticipate being able to cover any person's cost in its entirety. Investigators who have ongoing travel support from active grants are strongly discouraged from applying, particularly if they have also had travel previously supported by this mechanism. Priorities for funding include InterLymph members having maximum involvement in the consortium's pooling projects, active leadership role in InterLymph (i.e., in initiatives, working groups, coordinating committee, etc.), role in the annual meeting organization, and young investigators who are actively involved in data analysis and writing papers.

  Requests for travel support will be reviewed and ranked by the Coordinating Committee or their delegates who are not in conflict (i.e., no one may rank their own requests).

• Directions to the Meeting
  View Directions

  2013 InterLymph Symposium
  University of Dijon
  Faculty of Medicine
  7 Boulevard Jeanne d'Arc
  Dijon, France

  • Dijon-Bourgogne Airport (DIJ)
    The airport in Dijon, France only offers transportation using small planes to and from Bordeaux and Toulouse via Eastern Airways. These flights are available five days a week, but there is only one flight each day.

  • Train - Tramway
    The train à grande vitesse (TGV) is available to transport travelers from Paris (100 minutes away) and other major French cities to Dijon. There is also regular train service from a variety of destinations, including, but not restricted to, Italy (Milan, Turin, Florence and Rome), Switzerland, Luxembourg and Belgium.

    Train tickets can be purchased online within 90 days of the date of departure. Ticketing options include direct tickets or rail passes for those planning additional travel within France or Europe.

    Tickets can be picked up at the train station within the Gare de Lyon station or in Charles de Gaul (CDG) airport in the yellow automatic machines using the confirmation code and the same Visa card used to purchase the tickets.

    Upon arrival in Dijon, travellers can take a tram to reach the hotel. All suggested hotels are on the T1 line as is the Faculty at stop "CHU -Hôpitaux." Take T1 in the direction of "Quetigny" to get to the stop "CHU -Hôpitaux."

  • Car
    Dijon is well connected to the freeway and highway networks for those arriving by car. Note that traffic is limited in the center of the city, so it would be best to park cars for the duration of the visit.

    View driving directions to the Faculty of Medicine, University Dijon from Paris.

  • Taxi
    Dijon Taxi call center: 03 80 41 41 12

For other questions regarding travel, contact the Dijon Office of Tourism.

[Return to Top]

Abstract Submission Guidelines

1. The abstract submission deadline is May 1, 2013. InterLymph members can download the abstract submission form from the InterLymph SharePoint site. Others may request a copy of the form by contacting Aaron Norman. The completed abstract submission form should be e-mailed to Aaron Norman.
2. Abstracts will be published in the Meeting proceedings directly from the submission and must be submitted in the prescribed format.
3. Do not include graphics or tables.
4. Abstracts must be no more than 300 words (excluding the title, names, and affiliations).
5. The title must be less than 200 characters and presented in bold 12 point Arial font.
6. The authors must be listed with initials and surname in 11 point Arial font; for each author, indicate last name followed by the initials.
7. Affiliations should be indicated in order with a superscript number. The list of affiliations (institution, town, country) must follow the list of co-authors in 10 point Arial font (separated by commas if more than one affiliation per author).
8. The name of the presenting author must be underlined.
9. For the text, Arial 11 point font should be used with single line spacing and no right justification.
10. Format your abstract within the following sections: background and objective, methods, results, conclusion - please use abstract template.

[Return to Top]

Scientific Committee Members

• Olivier Casasnovas, M.D.
  Centre Hospitalier Universitaire Dijon
• Cindy Chang, Ph.D.
  Food and Drug Administration
• Brian Chiu, Ph.D.
  University of Chicago
• Alain Delmer, M.D.
  CHU de Reims
• Karin Ekstrom Smedby, Ph.D.
  Karolinska Institute
• Philippe Gaulard, M.D.
  Hospital Henri Mondor
• Thierry Lamy de la Chapelle, Ph.D.
  Université de Rennes
• Véronique Leblond, M.D.
  Département d' Hématologie Hôpital Pitié-Salpêtrière APHP
• Steven Le Gouill, Ph.D.
  CHU de Nantes
• Marc Maynadié, M.D., Ph.D.
  Université de Bourgogne
• Alain Monnereau, M.D., Ph.D.
  Institut Bergonié
• Lindsay Morton, Ph.D.
  National Cancer Institute
• Nat Rothman, M.D.
  National Cancer Institute
• Gilles Salles, M.D., Ph.D.
  Université de Lyon
• Susan Slager, Ph.D.
  Mayo Clinic
• Xavier Troussard, Ph.D.
  Registre des H'emopathies Malignes de Basse Normandie
• Claire Vajdic, Ph.D.
  University of New South Wales
• Anke van den Berg, Ph.D.
  University of Groningen
• Sophia Wang, Ph.D.
  City of Hope

[Return to Top]

Sponsors

• Lymphoma Coalition
• Faculté de Médecine de Dijon
• Institut de Veille Sanitaire
• Registre des hémopathies malignes de Côte d'Or
• INSERM
• Institut National du Cancer
• Université de Bourgogne
• Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang (GOELAMS)
• l'Institut Bergonié
• The Lymphoma Study Association (LYSA)
• Registre Régional des Hémopathies de Basse Normandie
• City of Dijon, France

[Return to Top]